Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Baseline characteristics of the included patients

From: Hallucinations and disturbed behaviour in the critically ill: incidence, patient characteristics, associations, trajectory, and outcomes

 

Overall (n = 7525)

Hallucination (n = 625)

No hallucination (n = 6900)

p value

Age, years

63.7 (51.1–74.1)

61.4 (47.8–72.2)

64.0 (51.5–74.2)

 < 0.001

Male gender—no. (%)

4619/7519 (61.4)

386 (61.8)

4233/6894 (61.4)

0.928

Body mass index, kg/m2

27.7 (24.0–32.2)

27.0 (23.9–31.8)

27.8 (24.0–32.3)

0.438

APACHE III

48.0 (35.0–64.0)

55.0 (39.0–73.0)

47.0 (34.2–63.0)

 < 0.001

ANZROD

2.4 (0.7–10.0)

4.1 (1.3–16.1)

2.3 (0.7–9.4)

 < 0.001

Type of admission—no. (%)

   

0.155

Medical

3854/7522 (51.2)

337/624 (54.0)

3517/6898 (51.0)

 

Surgical

3668/7522 (48.8)

287/624 (46.0)

3381/6898 (49.0)

 

Admitted from mental health facilities—no. (%)

27 (0.4)

4 (0.6)

23 (0.3)

0.278

Planned admission—no. (%)

2255 (30.0)

152 (24.3)

2103 (30.5)

0.001

MET call admission—no. (%)

1300/7524 (17.3)

116/624 (18.6)

1184 (17.2)

0.376

Cardiac arrest—no. (%)

198/7514 (2.6)

14/624 (2.2)

184/6890 (2.7)

0.603

Acute renal failure—no. (%)

216/7471 (2.9)

47/621 (7.6)

169/6850 (2.5)

 < 0.001

Alcohol withdrawal—no. (%)

4/7325 (0.1)

1/605 (0.2)

3/6720 (0.0)

0.292

Admission diagnosis—no. (%)

   

 < 0.001

Cardiovascular

2492/7522 (33.1)

142/624 (22.8)

2350/6898 (34.1)

 

Gastrointestinal

1280/7522 (17.0)

176/624 (28.2)

1104/6898 (16.0)

 

Gynaecological

14/7522 (0.2)

1/624 (0.2)

13/6898 (0.2)

 

Haematological

68/7522 (0.9)

8/624 (1.3)

60/6898 (0.9)

 

Metabolic

459/7522 (6.1)

40/624 (6.4)

419/6898 (6.1)

 

Musculoskeletal/Skin

159/7522 (2.2)

17/624 (2.8)

142/6898 (2.1)

 

Neurological

642/7522 (8.5)

59/624 (9.5)

583/6898 (8.5)

 

Renal/Genitourinary

361/7522 (4.8)

19/624 (3.0)

342/6898 (5.0)

 

Respiratory

1078/7522 (14.3)

73/624 (11.7)

1005/6898 (14.6)

 

Sepsis

708/7522 (9.4)

54/624 (8.7)

654/6898 (9.5)

 

Trauma

261/7522 (3.5)

35/624 (5.6)

226/6898 (3.3)

 

ICU source of admission—no. (%)

   

 < 0.001

Emergency department

1779 (23.6)

129 (20.6)

1650 (23.9)

 

Operating room

3645 (48.4)

287 (45.9)

3358 (48.7)

 

Ward

1215 (16.1)

106 (17.0)

1109 (16.1)

 

ICU other hospital

149 (2.0)

28 (4.5)

121 (1.8)

 

Other hospital

724 (9.6)

74 (11.8)

650 (9.4)

 

ICU same hospital

6 (0.1)

1 (0.2)

5 (0.1)

 

Other

7 (0.1)

0 (0.0)

7 (0.1)

 

Co-existing disorders—no. (%)

Diabetes

1059/1344 (78.8)

87/114 (76.3)

972/1230 (79.0)

0.475

Chronic lung disease

737 (9.8)

58 (9.3)

679 (9.8)

0.725

Chronic cardiovascular disease

339 (4.5)

34 (5.4)

305 (4.4)

0.228

Cirrhosis

560 (7.4)

84 (13.4)

476 (6.9)

 < 0.001

Chronic kidney disease

679 (9.0)

69 (11.0)

610 (8.8)

0.068

Chronic immune disease

192 (2.6)

20 (3.2)

172 (2.5)

0.288

Immunosuppression

585 (7.8)

54 (8.6)

531 (7.7)

0.391

Hepatic failure

104 (1.4)

15 (2.4)

89 (1.3)

0.031

Lymphoma

83 (1.1)

6 (1.0)

77 (1.1)

1.000

Metastatic cancer

330 (4.4)

28 (4.5)

302 (4.4)

0.919

Leukemia

153 (2.0)

14 (2.2)

139 (2.0)

0.657

Bipolar disorder

90 (1.2)

19 (3.0)

71 (1.0)

 < 0.001

Schizophrenia

117 (1.6)

30 (4.8)

87 (1.3)

 < 0.001

Organ support—no. (%)

ECMO

17/5193 (0.3)

4/467 (0.9)

13/4726 (0.3)

0.060

Vasopressor or inotropes

2697/5195 (51.9)

305/467 (65.3)

2392/4728 (50.6)

 < 0.001

Invasive ventilation

3906/6334 (61.7)

415/556 (74.6)

3491/5778 (60.4)

 < 0.001

Non-invasive ventilation

343/5224 (6.6)

33/469 (7.0)

310/4755 (6.5)

0.626

Renal replacement therapy

489/5331 (9.2)

107/486 (22.0)

382/4845 (7.9)

 < 0.001

Laboratory tests

pH

7.38 (7.32–7.43)

7.36 (7.30–7.42)

7.38 (7.32–7.43)

 < 0.001

PaO2/FiO2

305 (212–400)

280 (190–386)

309 (215–403)

 < 0.001

PaCO2, mmHg

40 (35–45)

41 (36–45)

40 (35–45)

0.464

Lactate, mmol/L

2.1 (1.5–3.2)

2.4 (1.7–4.2)

2.0 (1.4–3.1)

 < 0.001

Highest creatinine, µmol/L

91 (69–138)

102 (72–165)

91 (69–135)

 < 0.001

Lowest platelet, × 109/L

176 (125–239)

160 (99–233)

177 (126–239)

 < 0.001

Vital signs

Lowest MAP, mmHg

65 (59–72)

65 (58–71)

65 (59–73)

0.124

Highest RR, breaths/min

20 (15–25)

20 (16–25)

20 (15–25)

0.190

Highest temperature, ºC

37.2 (36.7–37.6)

37.3 (36.8–37.8)

37.2 (36.6–37.5)

 < 0.001

Urine output, mL

1509 (1085–2140)

1435 (921–2025)

1517 (1095–2150)

0.002

  1. Data are median (IQR) or N (%)
  2. APACHE is Acute Physiology and Chronic Health Evaluation, MET is medical emergency team, ICU is intensive care unit, ECMO is extracorporeal membrane oxygenation, MAP is mean arterial pressure, RR is respiratory rate